Abstract

Malignant transformation of a benign cystic teratoma of the ovary is only rarely seen. A review of the English literature revealed no reports of a malignant melanoma developing from concurrent primary endometrial carcinoma and ovarian cystic teratoma. We report herein a 54-year-old nulliparous woman who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy for a pelvic mass and was diagnosed by histopathological examination to have a malignant melanoma developing from concurrent primary endometrial carcinoma and ovarian cystic teratoma. No foci of primary malignant melanoma except for the ovary were found upon clinical examination. The patient received postoperative interferon alpha 2B and radiotherapy. She was still asymptomatic at 12 months of follow-up.

Highlights

  • Malignant transformation of a mature teratoma is quite rare

  • Squamous cell transformation accounts for 90-97% of all malignant transformations of mature teratomas

  • A total of 37 cases have been reported so far in the English literature [6,7,8,9,10,11,12]. This case is the first and only case in which a primary malignant melanoma developed from a mature teratoma of ovary while there was a concurrent primary endometrial carcinoma in uterus

Read more

Summary

INTRODUCTION

Malignant transformation of a mature teratoma is quite rare. Squamous cell transformation accounts for 90-97% of all malignant transformations of mature teratomas. Primary ovarian malignant melanoma was first reported in 1901 [5]. A total of 37 cases have been reported so far in the English literature [6,7,8,9,10,11,12]. This case is the first and only case in which a primary malignant melanoma developed from a mature teratoma of ovary while there was a concurrent primary endometrial carcinoma in uterus. Postsurgical histopathological examinations reveal concurrent primary ovarian and primary endometrial carcinoma at a rate of 5-15%, while the same rate climbs up to 30-40% in postmortem examinations [13,14]

Case report
Turkish Journal of Pathology
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call